Secreted frizzled-related protein 4 expression is positively associated with responsiveness to Cisplatin of ovarian cancer cell lines in vitro and with lower tumour grade in mucinous ovarian cancers

BMC Cell Biology

Volumn 13, Issue , 2012, Pages

  Saran, Uttara ^a   Arfuso, Frank ^a   Zeps, Nikolajs ^a,b   Dharmarajan, Arunasalam ^a,c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ST JOHN OF GOD HOSPITAL   (Australia)

^c CURTIN UNIVERSITY   (Australia)

Author keywords

Chemoresistance; Chemosensitivity; Cisplatin; Ovarian cancer; Secreted frizzled related protein 4; Tumour biopsy

Indexed keywords

BETA CATENIN; CISPLATIN; SECRETED FRIZZLED RELATED PROTEIN 4; WNT PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER GRADING; CELL VIABILITY; CHEMOSENSITIVITY; CONTROLLED STUDY; CYSTADENOCARCINOMA; DOWN REGULATION; DRUG RESPONSE; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; OVARY CANCER; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; TUMOR BIOPSY; WESTERN BLOTTING;

ADENOCARCINOMA, MUCINOUS; ANTINEOPLASTIC AGENTS; BETA CATENIN; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION; WNT PROTEINS;

EID: 84867038926     PISSN: None     EISSN: 14712121     Source Type: Journal    
DOI: 10.1186/1471-2121-13-25     Document Type: Article

References (45)

1. Gatcliffe TA, Monk BJ, Planutis K, Holcombe RF. Wnt signaling in ovarian tumorigenesis. Int J Gynecol Cancer 2008, 18(5):954-962. 10.1111/j.1525-1438.2007.01127.x, 2575063, 17986238.
2. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60(5):277-300. 10.3322/caac.20073, 20610543.
3. Landen CN, Birrer MJ, Sood AK. Early events in the pathogenesis of epithelial ovarian cancer. J Clin Oncol 2008, 26(6):995-1005. 10.1200/JCO.2006.07.9970, 18195328.
4. Shan W, Liu J. Epithelial ovarian cancer: focus on genetics and animal models. Cell Cycle 2009, 8(5):731-735. 10.4161/cc.8.5.7848, 19221485.
5. Fraser M, Leung B, Jahani-Asl A, Yan X, Thompson WE, Tsang BK. Chemoresistance in human ovarian cancer: the role of apoptotic regulators. Reprod Biol Endocrinol 2003, 1:66. 10.1186/1477-7827-1-66, 270001, 14609433.
6. Shahzad MM, Lopez-Berestein G, Sood AK. Novel strategies for reversing platinum resistance. Drug Resist Updat 2009, 12(6):148-152. 10.1016/j.drup.2009.09.001, 2789192, 19805003.
7. Balch C, Huang TH, Brown R, Nephew KP. The epigenetics of ovarian cancer drug resistance and resensitization. Am J Obstet Gynecol 2004, 191(5):1552-1572. 10.1016/j.ajog.2004.05.025, 15547525.
8. Polakis P. Wnt signaling and cancer. Genes Dev 2000, 14(15):1837-1851.
9. Chung MT, Lai HC, Sytwu HK, Yan MD, Shih YL, Chang CC, Yu MH, Liu HS, Chu DW, Lin YW. SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway. Gynecol Oncol 2009, 112(3):646-653. 10.1016/j.ygyno.2008.10.026, 19095296.
10. Filho RB, Domingues L, Naves L, Ferraz E, Alves A, Casulari LA. Polycystic ovary syndrome and hyperprolactinemia are distinct entities. Gynecol Endocrinol 2007, 23(5):267-272. 10.1080/09513590701297708, 17558684.
11. Komiya Y, Habas R. Wnt signal transduction pathways. Organogenesis 2008, 4(2):68-75. 10.4161/org.4.2.5851, 2634250, 19279717.
12. Lustig B, Behrens J. The Wnt signaling pathway and its role in tumor development. J Cancer Res Clin Oncol 2003, 129(4):199-221.
13. Lee AY, He B, You L, Dadfarmay S, Xu Z, Mazieres J, Mikami I, McCormick F, Jablons DM. Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma. Oncogene 2004, 23(39):6672-6676. 10.1038/sj.onc.1207881, 15221014.
14. Ricken A, Lochhead P, Kontogiannea M, Farookhi R. Wnt signaling in the ovary: identification and compartmentalized expression of wnt-2, wnt-2b, and frizzled-4 mRNAs. Endocrinology 2002, 143(7):2741-2749. 10.1210/en.143.7.2741, 12072409.
15. Fox S, Dharmarajan A. WNT signaling in malignant mesothelioma. Front Biosci 2006, 11:2106-2112. 10.2741/1953, 16720297.
16. Drake JM, Friis RR, Dharmarajan AM. The role of sFRP4, a secreted frizzled-related protein, in ovulation. Apoptosis 2003, 8(4):389-397. 10.1023/A:1024181203729, 12815282.
17. Guo K, Wolf V, Dharmarajan AM, Feng Z, Bielke W, Saurer S, Friis R. Apoptosis-associated gene expression in the corpus luteum of the rat. Biol Reprod 1998, 58(3):739-746. 10.1095/biolreprod58.3.739, 9510961.
18. Hsieh M, Mulders SM, Friis RR, Dharmarajan A, Richards JS. Expression and localization of secreted frizzled-related protein-4 in the rodent ovary: evidence for selective up-regulation in luteinized granulosa cells. Endocrinology 2003, 144(10):4597-4606. 10.1210/en.2003-0048, 12960062.
19. Lacher MD, Siegenthaler A, Jager R, Yan X, Hett S, Xuan L, Saurer S, Lareu RR, Dharmarajan AM, Friis R. Role of DDC-4/sFRP-4, a secreted frizzled-related protein, at the onset of apoptosis in mammary involution. Cell Death Differ 2003, 10(5):528-538. 10.1038/sj.cdd.4401197, 12728251.
20. Wolf V, Ke G, Dharmarajan AM, Bielke W, Artuso L, Saurer S, Friis R. DDC-4, an apoptosis-associated gene, is a secreted frizzled relative. FEBS Lett 1997, 417(3):385-389. 10.1016/S0014-5793(97)01324-0, 9409757.
21. Constantinou T, Baumann F, Lacher MD, Saurer S, Friis R, Dharmarajan A. SFRP-4 abrogates Wnt-3a-induced beta-catenin and Akt/PKB signalling and reverses a Wnt-3a-imposed inhibition of in vitro mammary differentiation. J Mol Signal 2008, 3:10. 10.1186/1750-2187-3-10, 2412851, 18452624.
22. Jones SE, Jomary C, Grist J, Stewart HJ, Neal MJ. Altered expression of secreted frizzled-related protein-2 in retinitis pigmentosa retinas. Invest Ophthalmol Vis Sci 2000, 41(6):1297-1301.
23. Kawano Y, Kypta R. Secreted antagonists of the Wnt signalling pathway. J Cell Sci 2003, 116(Pt 13):2627-2634.
24. Melkonyan HS, Chang WC, Shapiro JP, Mahadevappa M, Fitzpatrick PA, Kiefer MC, Tomei LD, Umansky SR. SARPs: a family of secreted apoptosis-related proteins. Proc Natl Acad Sci U S A 1997, 94(25):13636-13641. 10.1073/pnas.94.25.13636, 28358, 9391078.
25. Zhou Z, Wang J, Han X, Zhou J, Linder S. Up-regulation of human secreted frizzled homolog in apoptosis and its down-regulation in breast tumors. Int J Cancer 1998, 78(1):95-99. 10.1002/(SICI)1097-0215(19980925)78:1<95::AID-IJC15>3.0.CO;2-4, 9724099.
26. Bovolenta P, Esteve P, Ruiz JM, Cisneros E, Lopez-Rios J. Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease. J Cell Sci 2008, 121(Pt 6):737-746.
27. Ko J, Ryu KS, Lee YH, Na DS, Kim YS, Oh YM, Kim IS, Kim JW. Human secreted frizzled-related protein is down-regulated and induces apoptosis in human cervical cancer. Exp Cell Res 2002, 280(2):280-287. 10.1006/excr.2002.5649, 12413893.
28. Nojima M, Suzuki H, Toyota M, Watanabe Y, Maruyama R, Sasaki S, Sasaki Y, Mita H, Nishikawa N, Yamaguchi K, et al. Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer. Oncogene 2007, 26(32):4699-4713. 10.1038/sj.onc.1210259, 17297461.
29. Qi J, Zhu YQ, Luo J, Tao WH. Hypermethylation and expression regulation of secreted frizzled-related protein genes in colorectal tumor. World J Gastroenterol 2006, 12(44):7113-7117.
30. Suzuki H, Gabrielson E, Chen W, Anbazhagan R, van Engeland M, Weijenberg MP, Herman JG, Baylin SB. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 2002, 31(2):141-149. 10.1038/ng892, 11992124.
31. Zi X, Guo Y, Simoneau AR, Hope C, Xie J, Holcombe RF, Hoang BH. Expression of Frzb/secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness. Cancer Res 2005, 65(21):9762-9770. 10.1158/0008-5472.CAN-05-0103, 16266997.
32. Horvath LG, Lelliott JE, Kench JG, Lee CS, Williams ED, Saunders DN, Grygiel JJ, Sutherland RL, Henshall SM. Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer. Prostate 2007, 67(10):1081-1090. 10.1002/pros.20607, 17476687.
33. Marsit CJ, Karagas MR, Andrew A, Liu M, Danaee H, Schned AR, Nelson HH, Kelsey KT. Epigenetic inactivation of SFRP genes and TP53 alteration act jointly as markers of invasive bladder cancer. Cancer Res 2005, 65(16):7081-7085. 10.1158/0008-5472.CAN-05-0267, 16103055.
34. Farley J, Ozbun LL, Birrer MJ. Genomic analysis of epithelial ovarian cancer. Cell Res 2008, 18(5):538-548. 10.1038/cr.2008.52, 18427574.
35. He B, Lee AY, Dadfarmay S, You L, Xu Z, Reguart N, Mazieres J, Mikami I, McCormick F, Jablons DM. Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in beta-catenin-deficient human mesothelioma cells. Cancer Res 2005, 65(3):743-748.
36. Hrzenjak A, Tippl M, Kremser ML, Strohmeier B, Guelly C, Neumeister D, Lax S, Moinfar F, Tabrizi AD, Isadi-Moud N, et al. Inverse correlation of secreted frizzled-related protein 4 and beta-catenin expression in endometrial stromal sarcomas. J Pathol 2004, 204(1):19-27. 10.1002/path.1616, 15307134.
37. Wong SC, Lo SF, Lee KC, Yam JW, Chan JK, Wendy Hsiao WL. Expression of frizzled-related protein and Wnt-signalling molecules in invasive human breast tumours. J Pathol 2002, 196(2):145-153. 10.1002/path.1035, 11793365.
38. Gamallo C, Palacios J, Moreno G, Calvo de Mora J, Suarez A, Armas A. beta-catenin expression pattern in stage I and II ovarian carcinomas: relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome. Am J Pathol 1999, 155(2):527-536. 10.1016/S0002-9440(10)65148-6, 1866843, 10433945.
39. Wamunyokoli FW, Bonome T, Lee JY, Feltmate CM, Welch WR, Radonovich M, Pise-Masison C, Brady J, Hao K, Berkowitz RS, et al. Expression profiling of mucinous tumors of the ovary identifies genes of clinicopathologic importance. Clin Cancer Res 2006, 12(3 Pt 1):690-700.
40. Zou H, Molina JR, Harrington JJ, Osborn NK, Klatt KK, Romero Y, Burgart LJ, Ahlquist DA. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus. Int J Cancer 2005, 116(4):584-591. 10.1002/ijc.21045, 15825175.
41. Chien JR, Aletti G, Bell DA, Keeney GL, Shridhar V, Hartmann LC. Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer. J Cell Biochem 2007, 102(5):1117-1129. 10.1002/jcb.21552, 17879946.
42. He B, Reguart N, You L, Mazieres J, Xu Z, Lee AY, Mikami I, McCormick F, Jablons DM. Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations. Oncogene 2005, 24(18):3054-3058. 10.1038/sj.onc.1208511, 15735684.
43. White L, Dharmarajan A, Charles A. Caspase-14: a new player in cytotrophoblast differentiation. Reprod Biomed Online 2007, 14(3):300-307. 10.1016/S1472-6483(10)60871-1, 17359582.
44. Feng Han Q, Zhao W, Bentel J, Shearwood AM, Zeps N, Joseph D, Iacopetta B, Dharmarajan A. Expression of sFRP-4 and beta-catenin in human colorectal carcinoma. Cancer Lett 231(1):129-137.
45. Drake J, Shearwood AM, White J, Friis R, Zeps N, Charles A, Dharmarajan A. Expression of secreted frizzled-related protein 4 (SFRP4) in primary serous ovarian tumours. Eur J Gynaecol Oncol 2009, 30(2):133-141.